Delivery Order SPE2DB22D2206-SPE2DB22FEY65
Award Date
9/22/22
Potential Completion Date
10/14/22
Potential Value
$228K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $13,799.97 firm fixed price contract is for the supply of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product. The delivery order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designation was used. Amerisourcebergen Drug Corp has an extensive history...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is to provide REVLIMID 25 MG CAPSULE 100S, a pharmaceutical product, with a potential value of $107,931.18. The contract has a completion date of June 16, 2023. Amerisourcebergen Drug Corp has received numerous federal contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $49,926.80. The order is for REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of October 9, 2024 and is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of REVLIMID 5 MG CAPSULE 28S pharmaceutical products. The contract has a potential value of $13,799.97 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products from its corporate office location in Conshohocken,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $106,870.16 firm fixed price contract is for the delivery of REVLIMID 10 MG CAPSULE 100S, a pharmaceutical product, to support military treatment programs and facilities. The contract has a performance period ending on April 7, 2022 and was awarded on March...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide REVLIMID 25 MG CAPSULE 100S. The $107,931.18 award supports DLA Troop Support Medical programs and facilities. AmerisourceBergen Drug Corp, as a prime contractor, has a history of providing pharmaceuticals, medical supplies, and distribution services to government agencies such as the Department of Justice Federal Bureau of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide REVLIMID 10 MG CAPSULE 100S. The order has a potential value of $158,419.32 and a completion date of February 5, 2024. No set-aside was used for this award. AmerisourceBergen Drug Corp is a prime contractor that provides pharmaceutical products and distribution services to support DLA Troop Support Medical facilities. The company...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $89,155.06, is for the delivery of REVLIMID 5 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 7, 2025. The contract was awarded on February 13, 2025 and does not have a set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVLIMID 10 MG CAPSULE 100S, a pharmaceutical product. The contract has a ceiling value of $178,310.12 and is a firm fixed price contract. The contract is not set aside and is therefore open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
This contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product REVLIMID 10 MG CAPSULE 28S, with a ceiling value of $49,926.80 and a period of performance through August 2, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans...